cas 827-20-3|| where to buy 5-Fluoro-2-(trifluoromethyl)aniline

Nom du produit:5-Fluoro-2-(trifluoromethyl)aniline

IUPAC Name:5-fluoro-2-(trifluoromethyl)aniline

Unité d'emballage	Stock disponible	Prix($)
CM255193-5g	in stock	ǵưǤ
CM255193-10g	in stock	ǊǵȎ
CM255193-25g	in stock	ưźǤ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 827-20-3 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:827-20-3; Formule moléculaire:C7H5F4N; Point de fusion:-; Code SMILES:NC1=C(C=CC(F)=C1)C(F)(F)F; Densité:

: Numéro de catalogue:CM255193; Poids moléculaire:179.12; Point d'ébullition:185.6°C at 760 mmHg; N° Mdl:MFCD06660353; Stockage:Keep in dark place, inert atmosphere, store at 2-8°C.

: Benzenes; Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

: PF-06648671; The Journal of Medicinal Chemistry recently publishes an article titled, “Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer’s Disease”. Amyloid β-peptide (Aβ) accumulation is one of the key hallmarks of Alzheimer’s disease (AD). γ-secretase cleaves the amyloid precursor protein (APP) into pathologically relevant Aβs, and has been widely studied as a potential target for the treatment of AD.
Pfizer‘s PF-06648671 is a Gamma secretase modulator (GSM) targeting APP processing. It is found to have excellent central exposure in human and robust reduction of amyloidogenic forms (Aβ42) in cerebrospinal fluid (CSF).